Maximus (MMS) Q4 2025 Financial Results Summary

2025-11-20 · Stocks · QuoteReporter

Maximus (MMS) Q4 2025 Financial Results Summary

Maximus (NYSE: MMS) announced its fourth quarter and full-year financial results for fiscal year 2025 on November 20, 2025. The report highlighted margin expansion, strong cash generation, and the establishment of guidance for fiscal year 2026. The financial results reflect the company’s performance for the three months and year ended September 30, 2025.

Key Financial Highlights for Fiscal Year 2025

• Revenue:
• Full year revenue increased 2.4% to $5.43 billion, up from $5.31 billion in the previous year.

• Organic growth was 3.9%, primarily driven by high demand for clinical services within the U.S. Federal Services Segment.

• Margins:

• Operating margin was 9.7%, an increase from 9.2% in the prior year.

• Adjusted EBITDA margin improved to 12.9%, compared to 11.6% in the prior year.

• Earnings Per Share:

• Full year diluted earnings per share rose to $5.51, compared to $4.99 a year ago.

• Adjusted diluted earnings per share was $7.36, up from $6.11.

• Cash Flow:

• Cash flows from operating activities totaled $429 million.
• Free cash flow was reported at $366 million for the year.

• For Q4 alone, free cash flow was $642 million, against $401 million in the prior year.

• Shareholder Returns:

• The company repurchased a total of 5.8 million shares for $457 million during fiscal year 2025.
• A quarterly cash dividend of $0.30 per share has been declared, payable on December 1, 2025, to shareholders of record on November 14, 2025.

Segment Performance

U.S. Federal Services Segment:
– Revenue grew by 12.1% to $3.07 billion from $2.74 billion in the prior year.
– Operating margin for this segment was 15.3%, up from 12.2% year-over-year.

U.S. Services Segment:
– Revenue decreased by 7.7% to $1.76 billion, as compared to $1.91 billion from the previous year due to a decline in Medicaid-related activities.
– Operating margin dropped to 9.7%, down from 12.9% due to the absence of excess volumes experienced in the prior year.

Outside the U.S. Segment:
– Revenue decreased by 8.7% to $599.9 million from $657.1 million the previous year, largely due to divestitures.
– Operating margin improved to 3.7%, up from 1.2%, as a result of shedding more volatile elements of the portfolio.

Sales Pipeline and Financial Health

• Contract Awards: Total signed contract awards by September 30, 2025, stood at $4.7 billion, with contracts pending at $331 million.
• Sales Pipeline: The total sales pipeline reached $51.3 billion, with about 64% representing new work opportunities.
• Debt and Liquidity: At the end of the fiscal year, cash and cash equivalents were $222 million, with gross debt totaling $1.35 billion. The company reported a leverage ratio of 1.5x, down from 2.1x in the previous quarter, indicating improved financial flexibility.

Fiscal Year 2026 Outlook

Maximus has established guidance for fiscal year 2026, anticipating:
– Revenue between $5.225 billion and $5.425 billion.
– An adjusted EBITDA margin of approximately 13.7% for the full year.
– Adjusted diluted earnings per share expected to range between $7.95 and $8.25.
– Free cash flow is projected to be between $450 million and $500 million.

Conclusion

In summary, Maximus has demonstrated solid performance, highlighted by revenue growth and margin expansion in its U.S. Federal Services Segment while planning significant investments and strategic initiatives for the upcoming fiscal year. The company also continues to reward shareholders through dividends and share repurchases, showcasing its commitment to enhancing shareholder value.